Skip to content
Clinical Trials – home

Find therapies in clinical trials near you

recruiting
3 975
countries
28
conditions
2 106

23 trials match your criteria

Study of antibiotic treatment effectiveness in critically ill patients receiving drug combination therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin Sulfate

Study comparing dalbavancin to standard antibiotic treatment for patients with periprosthetic joint infection

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin Sodium

Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin Sulfate
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin Sodium

Viral infection

Recruiting

Study on Early Stopping of Antibiotics in Elderly Patients with Viral Infections Using Amoxicillin, Clavulanic Acid, Piperacillin, Tazobactam, and Pristinamycin

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Amoxicillin Sodium

Pyoderma

Recruiting

Study on Short vs. Standard Amoxicillin Treatment for Adults with Lower Limb Erysipelas

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin Sodium

Study of GNT0003 and imlifidase in adults with Crigler-Najjar syndrome who require daily phototherapy and have pre-existing AAV8 antibodies

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin Sodium

Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin Sulfate

Study of amoxicillin-clavulanic acid, piperacillin-tazobactam and meropenem dosing in critically ill children with systemic infections

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Amoxicillin Sodium
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin

Pouchitis

Recruiting

Study on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Amoxicillin Sodium
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.